Nystatin - Revision history

Danbot: Add AntibioticDose SMW query table for dynamic indications by disease

2026-03-20T20:38:22Z

Add AntibioticDose SMW query table for dynamic indications by disease

@@ Line 14: / Line 14: @@
 *Intestinal candidiasis
 **1-2 tabs (500,000 U) PO TID until 48 hrs after symptoms resolve
 ==Pediatric Dosing==
 ===Oral [[candidiasis]]===
 *Premature neonates:

Elcatracho: /* See Also */

2021-03-08T03:17:23Z

ClaireLewis: /* References */

2019-09-23T00:03:18Z

References

← Older revision		Revision as of 00:03, 23 September 2019
Line 63:		Line 63:
	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:ID]]

Ostermayer: Text replacement - "Category:Drugs" to "Category:Pharmacology"

2016-03-22T15:54:59Z

Text replacement - "Category:Drugs" to "Category:Pharmacology"

← Older revision		Revision as of 15:54, 22 March 2016
Line 62:		Line 62:
	==References==		==References==
	<references/>		<references/>
	[[Category:~~Drugs~~]]		[[Category:Pharmacology]]

Rossdonaldson1 at 15:42, 15 September 2015

2015-09-15T15:42:57Z

← Older revision		Revision as of 15:42, 15 September 2015
Line 1:		Line 1:
	==Administration==		==Administration==
	*Type: Antifungal		*Type: [[Antifungal]]
	*Dosage Forms:		*Dosage Forms:
	*Routes of Administration:		*Routes of Administration:
Line 9:		Line 9:

	==Adult Dosing==		==Adult Dosing==
	*Oral ~~Candidiasis:~~		===[[Candidiasis]]===
			*Oral candidiasis
	**4-6 mL PO QID of 100,000U/mL until 48 hrs after symptoms resolve		**4-6 mL PO QID of 100,000U/mL until 48 hrs after symptoms resolve
	*Intestinal candidiasis		*Intestinal candidiasis
Line 15:		Line 16:

	==Pediatric Dosing==		==Pediatric Dosing==
	*Oral candidiasis		===Oral [[candidiasis]]===
	**Premature neonates:		*Premature neonates:
	***1 mL PO QID of 100,000 U/mL until 48 hrs after symptoms resolve		**1 mL PO QID of 100,000 U/mL until 48 hrs after symptoms resolve
	**Infants:		*Infants:
	***2 mL PO QID of 100,000 U/mL until 48 hrs after symptoms resolve		**2 mL PO QID of 100,000 U/mL until 48 hrs after symptoms resolve
	**Children:		*Children:
	***4-6 mL PO QID of 100,000 U/mL until 48 hrs after symptoms resolve		**4-6 mL PO QID of 100,000 U/mL until 48 hrs after symptoms resolve

	==Special Populations==		==Special Populations==
	*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: C		*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: C
	*[[Lactation risk categories\|Lactation risk]]: Safe		*[[Lactation risk categories\|Lactation risk]]: Safe

	===Renal Dosing===		===Renal Dosing===
	*Adult: not defined		*Adult: not defined
Line 39:		Line 41:
	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*Hypersensitivity ~~rxn~~		*Hypersensitivity reaction

	===Common===		===Common===
	*Nausea / Vomiting		*[[Nausea]] / [[Vomiting]]
	*Diarrhea		*[[Diarrhea]]
	*Abdominal ~~Pain~~		*[[Abdominal pain]]

	==Pharmacology==		==Pharmacology==
Line 61:		Line 63:
	<references/>		<references/>
	[[Category:Drugs]]		[[Category:Drugs]]
	*Epocrates 2015

Bisakson: /* Pediatric Dosing */

2015-09-14T23:20:47Z

Pediatric Dosing

← Older revision		Revision as of 23:20, 14 September 2015
Line 15:		Line 15:

	==Pediatric Dosing==		==Pediatric Dosing==
			*Oral candidiasis
			**Premature neonates:
			***1 mL PO QID of 100,000 U/mL until 48 hrs after symptoms resolve
			**Infants:
			***2 mL PO QID of 100,000 U/mL until 48 hrs after symptoms resolve
			**Children:
			***4-6 mL PO QID of 100,000 U/mL until 48 hrs after symptoms resolve

	==Special Populations==		==Special Populations==

Bisakson: /* Mechanism of Action */

2015-09-14T23:18:22Z

Mechanism of Action

← Older revision		Revision as of 23:18, 14 September 2015
Line 45:		Line 45:

	==Mechanism of Action==		==Mechanism of Action==
			*Increases cell membrane permeability by binding to sterols

	==Comments==		==Comments==

Bisakson: /* Hepatic Dosing */

2015-09-14T23:17:50Z

Hepatic Dosing

← Older revision		Revision as of 23:17, 14 September 2015
Line 24:		Line 24:

	===Hepatic Dosing===		===Hepatic Dosing===
	*Adult:		*Adult: not defined
	*Pediatric:		*Pediatric: not defined

	==Contraindications==		==Contraindications==

Bisakson: /* Renal Dosing */

2015-09-14T23:17:29Z

Renal Dosing

← Older revision		Revision as of 23:17, 14 September 2015
Line 20:		Line 20:
	*[[Lactation risk categories\|Lactation risk]]: Safe		*[[Lactation risk categories\|Lactation risk]]: Safe
	===Renal Dosing===		===Renal Dosing===
	*Adult:		*Adult: not defined
	*Pediatric:		*Pediatric: not defined

	===Hepatic Dosing===		===Hepatic Dosing===
	*Adult:		*Adult:

Bisakson: /* Adult Dosing */

2015-09-14T23:17:15Z

Adult Dosing

← Older revision		Revision as of 23:17, 14 September 2015
Line 9:		Line 9:

	==Adult Dosing==		==Adult Dosing==
			*Oral Candidiasis:
			**4-6 mL PO QID of 100,000U/mL until 48 hrs after symptoms resolve
			*Intestinal candidiasis
			**1-2 tabs (500,000 U) PO TID until 48 hrs after symptoms resolve

	==Pediatric Dosing==		==Pediatric Dosing==

← Older revision		Revision as of 03:17, 8 March 2021
Line 59:		Line 59:

	==See Also==		==See Also==
			*[[Antifungals]]
			*[[Fungal infections]]

	==References==		==References==